Cargando…
18F-FDG PET Radiomics as Predictor of Treatment Response in Oesophageal Cancer: A Systematic Review and Meta-Analysis
The best treatment strategy for oesophageal cancer patients achieving a complete clinical response after neoadjuvant chemoradiation is a burning topic. The available diagnostic tools, such as 18F-FDG PET/CT performed routinely, cannot accurately evaluate the presence or absence of the residual tumou...
Autores principales: | Deantonio, Letizia, Garo, Maria Luisa, Paone, Gaetano, Valli, Maria Carla, Cappio, Stefano, La Regina, Davide, Cefali, Marco, Palmarocchi, Maria Celeste, Vannelli, Alberto, De Dosso, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965232/ https://www.ncbi.nlm.nih.gov/pubmed/35371989 http://dx.doi.org/10.3389/fonc.2022.861638 |
Ejemplares similares
-
Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes
por: Roesel, Raffaello, et al.
Publicado: (2023) -
Radiomics analysis improves (18)FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2021) -
Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022) -
External validation of (18)F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy
por: Valkema, Maria J., et al.
Publicado: (2023) -
Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?
por: De Bari, Berardino, et al.
Publicado: (2022)